The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.80
Ask: 3.84
Change: 0.09 (2.43%)
Spread: 0.04 (1.053%)
Open: 3.80
High: 3.80
Low: 3.80
Prev. Close: 3.71
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Argentina approves Harpin as a seed treatment

1 Sep 2021 07:00

RNS Number : 1012K
Plant Health Care PLC
01 September 2021
 

RNS

1 September 2021

 

PLANT HEALTH CARE plc

("Plant Health Care" or the "Company")

 

Argentina approves Harpin ab for use as a seed treatment in Corn and Soybeans

 

Plant Health Care® (AIM: PHC.L), a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce the registration approval of Harpin ab for use as a seed treatment in Argentina.

 

The regulatory process in Argentina for agricultural products involves detailed review and approval by Senasa, the Country's National Food Safety and Quality Service, which classified Harpin ab as a biostimulant organic-chemical fertilizer. This confirms the Argentinian government's commitment to promoting cost effective, sustainable and safe products.

 

Highlights

· Corn and soybeans are the first crops to receive regulatory approval for Harpin ab in Argentina.

· Argentina has 24 million hectares (60 million acres) of corn and soybeans planted in the current season. Growers spent more than $100m on soybean seed treatments in Argentina in the most recent season. The size of the biological market in soybeans is growing rapidly and was about $75m in 2021.

· The Company is currently working with multiple organizations that are evaluating Harpin ab and will select in-country distribution partners in due course.

 

Harpin ab works by triggering the plant's own self defense systems, leading to a robust physiological response, in a manner similar to vaccinations in humans. The plant responds with improved crop quality, nutrient use efficiency, tolerance to abiotic stress and ultimately, increased yield. Being a biological product, Harpin αβ has a very favorable human and environmental safety profile.

 

Chris Richards, CEO of Plant Health Care, said: ‟Harpin ab registration in Argentina is key to the further expansion of Harpin ab use into large row crop markets."

 

 

For further information, please contact:

 

Plant Health Care plc- Tel: +1 919 926 1600

Chris Richards, CEO

 

Arden Partners plc - Nomad & Joint Broker Tel: +44 (0) 20 7614 5900

John Llewellyn-Lloyd / Antonio Bossi

 

Cenkos Securities plc - Joint Broker Tel: +44 (0) 20 7391 8900

Neil McDonald / Peter Lynch

 

Vox Markets - Digital investor relations Tel: +44 (0) 7866 384707

Paul Cornelius / Kat Perez

About Plant Health Care

Plant Health Care offers products to improve the health, vigour and yield of major field crops such as corn, soybeans, potatoes and rice, as well as specialty crops such as fruits and vegetables. We operate globally through subsidiaries, distributors and supply agreements with major industry partners. Our innovative, patent-protected biological products help growers to protect their crops from stress and diseases, and to produce higher quality fruit and vegetables, with a favourable environmental profile. Find out more at Vox Markets and the company website: www.planthealthcare.com

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSDLFDSEFSELA
Date   Source Headline
25th Oct 20109:34 amRNSLicensing Agreement with XS Inc
1st Oct 20103:00 pmRNSTotal Voting Rights
9th Sep 20107:00 amRNSAgreement with Germains Seed Technology
1st Sep 201010:30 amRNSTotal Voting Rights
24th Aug 20103:30 pmRNSPosting of Interim Report
19th Aug 201012:30 pmRNSBlocklisting Interim Review
18th Aug 201010:15 amRNSAdditional Listing
16th Aug 20107:00 amRNSHalf Yearly Report
26th Jul 20107:00 amRNSAgreement with Syngenta Crop Protection Inc.
12th Jul 201012:30 pmRNSHolding(s) in Company
1st Jul 201010:05 amRNSHolding(s) in Company
1st Jul 201010:00 amRNSHolding(s) in Company
30th Jun 20104:45 pmRNSTotal Voting Rights
29th Jun 20109:30 amRNSHolding(s) in Company
16th Jun 201011:20 amRNSTrading Update
28th May 20107:00 amRNSSale of PHC Reclamation Inc.
10th May 20107:00 amRNSMyconate Collaboration with Brazilian Government
6th May 20107:00 amRNSMyconate Agreement with Legacy Seeds Inc
30th Apr 20109:30 amRNSTotal Voting Rights
28th Apr 20109:30 amRNSAdditional Listing
28th Apr 20107:00 amRNSPatent Application for AirStrike programme
26th Apr 20107:00 amRNSMyconate IP Agreement with Bayer CropScience
21st Apr 20106:00 pmRNSVesting of Shares under LTIP
20th Apr 20107:00 amRNSHarpin agreement with Plant Foods Inc.
15th Apr 20105:00 pmRNSResult of AGM
22nd Mar 20107:00 amRNSPatent Protection Application
15th Mar 20103:30 pmRNSDirector/PDMR Shareholding
8th Mar 201012:45 pmRNSPublication of Annual Report & Notice of AGM
1st Mar 201010:00 amRNSTotal Voting Rights
19th Feb 201010:30 amRNSDirector/PDMR Shareholding
16th Feb 201010:36 amRNSAdditional Listing and Directors' Shareholdings
16th Feb 20109:51 amRNSDual Listing on Channel Islands Stock Exchange
15th Feb 201012:26 pmRNSBlocklisting
15th Feb 20107:00 amRNSFinal Results
10th Feb 20107:00 amRNSSupply Agreement
4th Feb 20107:00 amRNSOrder for Myconate
2nd Feb 20107:00 amRNSTrial Results
1st Feb 201010:22 amRNSTotal Voting Rights
27th Jan 20107:00 amRNSTrading Statement
22nd Jan 20105:41 pmRNSAdditional Listing
12th Jan 20104:03 pmRNSDirector Declaration
31st Dec 20091:05 pmRNSTotal Voting Rights
29th Dec 20094:26 pmRNSAdditional Listing
8th Dec 20095:42 pmRNSAdditional Listing
1st Dec 200911:08 amRNSTotal Voting Rights
27th Nov 20092:55 pmRNSDirector/PDMR Shareholding
13th Nov 200911:52 amRNSHolding(s) in Company
10th Nov 20095:29 pmRNSAdditional Listing
6th Nov 200912:53 pmRNSAdditional Listing
4th Nov 20091:52 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.